Amicus Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 29.20 M | $238.28 M | 2.60% | 9.49% |
| VANGUARD GROUP INC | 05/09/2025 | 29.05 M | $237.05 M | -0.71% | 9.44% |
| BLACKROCK, INC. | 05/02/2025 | 27.82 M | $227.04 M | -0.30% | 9.04% |
| PERCEPTIVE ADVISORS LLC | 05/15/2025 | 21.46 M | $175.15 M | -11.47% | 6.98% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2025 | 20.50 M | $167.28 M | -11.54% | 6.66% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 05/09/2025 | 14.78 M | $120.59 M | -5.25% | 4.80% |
| REDMILE GROUP, LLC | 05/15/2025 | 9.53 M | $77.79 M | 35.14% | 3.10% |
| STATE STREET CORP | 05/15/2025 | 9.52 M | $77.68 M | -8.13% | 3.09% |
| CITADEL ADVISORS LLC | 05/15/2025 | 7.84 M | $63.97 M | -4.86% | 2.55% |
| PALO ALTO INVESTORS LP | 05/15/2025 | 7.35 M | $59.94 M | -4.14% | 2.39% |
| MACQUARIE GROUP LTD | 05/15/2025 | 6.82 M | $55.61 M | 2.82% | 2.21% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 6.76 M | $55.20 M | 2.31% | 2.20% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 5.60 M | $45.69 M | 38.70% | 1.82% |
| JPMORGAN CHASE & CO | 05/12/2025 | 4.89 M | $39.94 M | -32.16% | 1.59% |
| VESTAL POINT CAPITAL, LP | 05/15/2025 | 4.28 M | $34.88 M | 27.61% | 1.39% |
| AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 3.90 M | $31.82 M | -0.08% | 1.27% |
| 05/12/2025 | 3.52 M | $28.74 M | 100.00% | 1.14% | |
| NORTHERN TRUST CORP | 05/13/2025 | 3.38 M | $27.54 M | 0.10% | 1.10% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 3.36 M | $27.41 M | 635.07% | 1.09% |
| JANUS HENDERSON GROUP PLC | 05/15/2025 | 3.32 M | $28.00 M | -2.18% | 1.08% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 05/02/2025 | 3.28 M | $26.74 M | 0.28% | 1.06% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 2.99 M | $24.36 M | 100.00% | 0.97% |
| NOVO HOLDINGS A/S | 05/15/2025 | 2.75 M | $22.44 M | 10.00% | 0.89% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 2.70 M | $22.06 M | 7.74% | 0.88% |
| INVESCO LTD. | 05/12/2025 | 2.66 M | $21.72 M | 4.14% | 0.87% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 2.49 M | $20.33 M | -3.70% | 0.81% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/14/2025 | 2.47 M | $20.16 M | 36.88% | 0.80% |
| BLACKSTONE INC. | 05/15/2025 | 2.47 M | $20.13 M | 0.00% | 0.80% |
| MORGAN STANLEY | 05/15/2025 | 2.43 M | $19.81 M | 14.44% | 0.79% |
| D. E. SHAW & CO., INC. | 05/15/2025 | 2.29 M | $18.69 M | 46.77% | 0.74% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 2.29 M | $18.65 M | 0.00% | 0.74% |
| GRANITE INVESTMENT PARTNERS, LLC | 05/13/2025 | 2.09 M | $17.06 M | 25.21% | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 05/01/2025 | 2.01 M | $16.40 M | 46.61% | 0.65% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 1.63 M | $13.72 M | 7.29% | 0.53% |
| ABRDN PLC | 05/13/2025 | 1.59 M | $12.95 M | 14.91% | 0.52% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 1.56 M | $12.75 M | -25.92% | 0.51% |
| SQUAREPOINT OPS LLC | 05/15/2025 | 1.54 M | $12.57 M | 8.66% | 0.50% |
| PANAGORA ASSET MANAGEMENT INC | 05/15/2025 | 1.44 M | $11.79 M | 0.74% | 0.47% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 1.39 M | $11.36 M | 368.25% | 0.45% |
| PROSIGHT MANAGEMENT, LP | 05/15/2025 | 1.38 M | $11.26 M | 49.93% | 0.45% |
| UBS GROUP AG | 05/13/2025 | 1.34 M | $10.91 M | 23.78% | 0.43% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 1.28 M | $10.47 M | -6.25% | 0.42% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 1.07 M | $8.75 M | 11.87% | 0.35% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 1.07 M | $8.74 M | 33.30% | 0.35% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 1.04 M | $8.48 M | 26.38% | 0.34% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 1.03 M | $8.43 M | 822.77% | 0.34% |
| MAN GROUP PLC | 05/15/2025 | 1.02 M | $8.31 M | 1,736.73% | 0.33% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 978.31 K | $7.98 M | -1.13% | 0.32% |
| PRIMECAP MANAGEMENT CO/CA/ | 05/09/2025 | 919.50 K | $7.50 M | -1.64% | 0.30% |
| JANE STREET GROUP, LLC | 05/19/2025 | 914.56 K | $7.46 M | 182.04% | 0.30% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Amicus Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 399 institutional investors and hedge funds held shares of Amicus Therapeutics, Inc.. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 29.2 M
VANGUARD GROUP INC: 29.05 M
BlackRock, Inc.: 27.82 M
PERCEPTIVE ADVISORS LLC: 21.46 M
Avoro Capital Advisors LLC: 20.5 M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC: 14.78 M
99.69% of Amicus Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 378.06 M shares in the last 24 months. This purchase volume represents approximately $2.29 B in transactions.